JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
Morning Movers 5/11: RGDX, AGEN, RZ, MFB, LM Higher; PCLN, BEE, TIXC, BPZ, RCKY Lower
-
Notable Analyst Rating Changes 02/26: RST, AZN/GSK, CHA/CHU, OSIS, LAMR Upgraded; PALM, DPS, ATHN, FLR, MOT Downgraded
-
J.P. Morgan Upgrades GlaxoSmthKline (GSK) to Neutral
-
Notable Analyst Rating Changes 10/14: CSC, GSK, SNY, ABX, CNO, HOG, TEL Upgrade; VLO, JBLU, AGCO Downgrade
-
David Moenning's Daily State of the Markets: 6/11
-
David Moenning's Daily State of the Markets: 3/18
-
Notable Analyst Rating Changes 3/17: TGT, HD, JPM Upgraded; LVS, MS, FSLR Downgraded
-
Notable Analyst Rating Changes 1/26: LEN, GRMN, LUV, PETM, LEAP Upgraded; BHP, BAC, USB, AFL, ENR Downgraded
-
Notable Analyst Rating Changes 11/14: CLX, LDK, ALO, URBN Upgraded; GSK, EMR, LHO, UDR Downgraded
-
David Moenning's Daily State of the Markets: 10/16
-
Notable Analyst Rating Changes 4/18: GOOG, SCHW, ADS Upgraded; NOK, GPS, GSK, ISRG Downgraded
-
J.P. Morgan Downgrades GlaxoSmithKline (GSK) to Underweight
-
Pre-Open Movers 4/16: POZEN (POZN) Surges On FDA Approval; Movado (MOV) Higher on Upgrade
-
Major Drug Companies Fall to New 52-Week Lows (PFE, GSK, MRK, LLY, BMY)
-
David Moenning's Daily State of the Markets: 2/11
